section name header

Overview

Topic Editor: Grant E. Fraser, M.D., FRACGP, FACRRM, ASTEM

Review Date: 9/17/2012


Definition

Traveler's diarrhea is defined as diarrhea characterized by gteq3 unformed stools over a period of 24 hours occurring during travel to a less economically developed country

Description

Epidemiology

Incidence/Prevelence

Age

Gender

Risk Factors

Etiology

Pathophysiology


History & Physical Findings

History

Physical findings on examination


Laboratory & Diagnostic Testing/Findings

The diagnosis of traveler's diarrhea is mainly presumptive, based on the occurrence of diarrhea while visiting a high-risk region of the world. Mild cases do not require laboratory investigation, as they resolve within a few days without medication. However, severe cases can require antibiotic treatment and may depend on identification of the causative organism in order to select the appropriate antimicrobial therapy. Stool culture, and sometimes blood culture, can be useful.

Other laboratory test findings

Differential Diagnosis

Treatment/Medications

General treatment items

Pharmacological treatment

Medications indicated with specific doses

Antibiotics

Anti-protozoal

Antimotility agents

Adjunctive agents

Dietary or Activity restrictions


Follow-up

Monitoring

  • Patients should be advised to follow recommended dietary restrictions during recovery
  • Occasional loose stools that occur post treatment do not require further intervention
  • If diarrhea persists along with fever and bloody stools, further medical intervention is required
  • If dehydration occurs, medical intervention is required

Complications

  • Antibiotic linked C. difficile infection
  • Chronic carrier state (particularly salmonella)
  • Chronic intestinal inflammation
  • Dehydration
  • Hemolytic uremic syndrome
  • Irritable bowel syndrome
  • Quinolone therapy may cause tendonitis (typically only with chronic use)
  • Shock
  • Temporary lactose intolerance

Miscellaneous

Prevention

  • During travel, travelers must avoid consumption of uncooked or raw meat/fish/vegetables/milk products, unpeeled fruits/vegetables, tap water, food prepared by street vendors
  • It is recommended to consume boiled/bottled water and well cooked or packaged food served hot
  • Prophylaxis
    • Prophylaxis with antibiotics is not usually recommended except in cases of diplomats and the severely immunocompromised. Ciprofloxacin or rifaximin may be used
    • Bismuth subsalicylate has been shown to be significantly effective for prophylaxis
  • Vaccination
    • Oral cholera vaccine containing killed whole V. cholerae O1 bacteria and the recombinant cholera toxin B subunit may provide short-term protection against enterotoxigenic E. coli (ETEC); however, the vaccine is not available in the U.S.
    • Vaccination is recommended for at-risk travelers, especially those who might be expected to have high exposure at their travel destination or who might be at significant personal risk in the event of fluid loss

Prognosis

  • Traveler's diarrhea is usually not life-threatening, but can cause severe limitations to everyday activities
  • This condition is self-limiting, typically lasting 3–5 days
  • Most cases resolve without antibiotics

Pregnancy/pediatric effects on the condition

  • Pregnant women have a higher risk of traveler's diarrhea due to decreased stomach acidity and increased GI transit time
  • Quinolones are contraindicated during pregnancy, generally azithromycin is the antibiotic of choice

Synonyms

  • Infectious diarrhea

ICD-9-CM

  • 009.2 Infectious diarrhea
  • 009.3 Diarrhea of presumed infectious origin

ICD-10-CM

  • A09.0 Other and unspecified gastroenteritis of infectious origin

References

  1. Centers for Disease Control and Prevention. Travelers'Diarrhea. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/travelersdiarrhea_g.htm. Updated Nov 21, 2006. Last accessed July 11, 2012.
  2. Greenwood Z, Black J, Weld L, et al. Gastrointestinal infection among international travelers globally. J Travel Med. 2008;15(4):221-8. abstract
  3. Diemert DJ. Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev. 2006;19(3):583-94. abstract
  4. Bauche JC, DuPont HL. New developments in traveler's diarrhea. Gastroenterol Hepatol. 2011;7(2):88-95. abstract
  5. DuPont H, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med. 1993;328:1821-27. abstract
  6. Yates J. Traveler's diarrhea. Am Fam Physician. 2005;71(11):2095-100. abstract
  7. Koo HL, Ajami NJ, Jiang ZD, et al. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010;48(5):1673-76. abstract
  8. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009;80(4):609-14. abstract
  9. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for self-therapy of travelers' diarrhea. J Travel Med. 2009;16(3):161-71. abstract
  10. DuPont HL, Jiang ZD, Okhuysen PC. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med. 2005;142(10):805-12. abstract
  11. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep. 2011;13(5):402-7. abstract
  12. Jelinek T, Kollaritsch H. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Expert Rev Vaccines. 2008;7(5):561-67. abstract
  13. Hill DR, Beeching NJ. Travelers' diarrhea. Curr Opin Infect Dis. 2010;23(5):481-87. abstract
  14. Hill DR, Ericsson CD, Pearson RD. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(12):1499-539. abstract